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 ABSTRACT 
The human skeleton represents the supporting structure of the organism and accounts for 
about 20 percent of the total body mass. Despite its intrinsic capacity to regenerate and self-
repair, this ability is limited and repair therapies are needed in a large number of clinical 
cases. Bone engineering holds the potential to alleviate the increasing burden of bone 
deficiencies by constructing viable substitutes for replacement therapies. However, before 
bone engineering can realize its full potential, it is critical to assess the suitability of stem 
cells derived from different sources for the large-scale construction of bone-engineered 
substitutes. 
The aim of the present thesis was to evaluate the potential of stem cells of embryonic 
origin for bone engineering applications. In particular, we investigated the potential of two 
cell lines, denoted matrix free-growth human embryonic stem cells (MFG-hESCs) and 
embryonic stem cell-derived mesodermal progenitors (hES-MPs). Cells were cultured in vitro 
under static and dynamic conditions, with and without ceramic and metal scaffolds as well as 
implanted in vivo as cell/scaffold constructs. 
The results demonstrate that, under similar in vitro conditions, both MFG-hESCs and 
hES-MPs undergo osteogenic differentiation and display higher mineralization properties 
compared to human mesenchymal stem cells (hMSCs). Differentiation was associated with 
alteration in the expression of genes involved in ossification, and resulted in the synthesis of a 
matrix with high content of calcium phosphate deposits. Interestingly, following osteogenic 
differentiation, MFG-hESCs displayed decreased expression of genes involved in 
pluripotency and self-renewal, which are also responsible for teratoma formation. In 
particular, hES-MPs displayed morphological and molecular characteristics typical of 
hMSCs, but exhibited longer telomeric sequences and significantly higher proliferation ability 
both in monolayer and three-dimensional cultures. In addition, after flow perfusion 
stimulation, hES-MPs displayed increased tissue formation, denser collagen network and 
higher calcium content compared to hMSCs. Not least, hES-MPs displayed an immune 
profile similar to hMSCs, but did not express HLA-DR molecules. Noteworthy, the 
expression of HLA-DR was not stimulated following expansion, osteogenic differentiation 
and treatment with INF-γ. In line with this, hES-MPs did not elicit an immune response after 
subcutaneous implantation in immunocompetent mice. Finally, it was demonstrated that 
titanium scaffolds supported the attachment and growth of hES-MPs in vitro, and did not 
seem to affect the expression of genes involved in osteogenesis. 
In conclusion, this thesis demonstrates that cells of embryonic origin, under experimental 
in vitro conditions, display some comparative advantages over stem cells derived from adult 
tissues, which are essential prerequisites for the large-scale production of bone substitutes for 
replacement therapies. Not least, MFG-hESCs and hES-MPs represent optimal cell 
technology platforms for the generation of experimental models to study bone histogenesis 
and explore tissue functionality in different conditions. 
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